Intra-tumoral BT-001 injection in combination with IV pembrolizumab was well tolerated with a manageable safety profile. Tumor shrinkage was observed in both injected and non-injected lesions. BT-001 ...
COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology Inc. (Matica Bio), a CDMO specializing in viral vector development and manufacturing, announced the signing of a Letter of Intent (LOI) ...
ADZE is thrilled to welcome Dr. Paola Grandi to our team as we advance our pipeline of systemically deliverable oncolytic immunotherapies into the clinic. ADZE is thrilled to welcome Dr. Paola Grandi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback